Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1984 2
1985 3
1986 5
1987 3
1988 8
1989 2
1990 4
1991 4
1992 2
1993 2
1994 2
1996 4
1999 1
2000 1
2001 1
2005 3
2006 2
2007 2
2008 1
2009 2
2012 1
2014 1
2016 1
2017 4
2018 4
2019 3
2021 2
2022 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
The following terms were ignored: "", OR
Page 1
Butoconazole.
[No authors listed] [No authors listed] 2018 Oct 31. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2018 Oct 31. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000484 Free Books & Documents. Review.
Vaginal butoconazole has not been studied during breastfeeding. About 5.5% of a vaginal dose is absorbed and its plasma half-life is 21 to 24 hours. Because there is no published experience with butoconazole during breastfeeding, other agents may be preferred, espec …
Vaginal butoconazole has not been studied during breastfeeding. About 5.5% of a vaginal dose is absorbed and its plasma half-life is …
N-Methylfulleropyrrolidine-Based Multimode Sensor for Determination of Butoconazole Nitrate.
Ţuchiu BM, Staden RS, van Staden JKF, Aboul-Enein HY. Ţuchiu BM, et al. ACS Omega. 2022 Nov 8;7(46):42537-42544. doi: 10.1021/acsomega.2c05904. eCollection 2022 Nov 22. ACS Omega. 2022. PMID: 36440171 Free PMC article.
., stochastic mode, amperometric mode, voltammetric mode) based on graphite paste modified with N-methylfulleropyrrolidine was proposed for the determination of butoconazole nitrate in its pharmaceutical formulation. The stochastic mode and square wave voltammetry mode wer …
., stochastic mode, amperometric mode, voltammetric mode) based on graphite paste modified with N-methylfulleropyrrolidine was proposed for …
Three-day treatment of vulvovaginal candidiasis.
Adamson GD. Adamson GD. Am J Obstet Gynecol. 1988 Apr;158(4):1002-5. doi: 10.1016/0002-9378(88)90114-7. Am J Obstet Gynecol. 1988. PMID: 3364485
Butoconazole nitrate, a newer imidazole, is effective for the treatment of vulvovaginal candidiasis when administered as a vaginal cream. ...The suppository form of butoconazole may offer a valuable therapeutic alternative for patients who wish to use it instead of …
Butoconazole nitrate, a newer imidazole, is effective for the treatment of vulvovaginal candidiasis when administered as a vaginal cr …
Efficacy of antifungal drugs in the treatment of vulvovaginal candidiasis: a Bayesian network meta-analysis.
Qin F, Wang Q, Zhang C, Fang C, Zhang L, Chen H, Zhang M, Cheng F. Qin F, et al. Infect Drug Resist. 2018 Oct 17;11:1893-1901. doi: 10.2147/IDR.S175588. eCollection 2018. Infect Drug Resist. 2018. PMID: 30425538 Free PMC article.
The relative risk of VVC associated with ten drugs, including placebo, fluconazole, clotrimazole, miconazole, itraconazole, ketoconazole, econazole, butoconazole, terbinafine, and terconazole, was analyzed. The following drugs appeared to show more efficacy than placebo in …
The relative risk of VVC associated with ten drugs, including placebo, fluconazole, clotrimazole, miconazole, itraconazole, ketoconazole, ec …
An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.
Seidman LS, Skokos CK. Seidman LS, et al. Infect Dis Obstet Gynecol. 2005 Dec;13(4):197-206. doi: 10.1080/10647440500240615. Infect Dis Obstet Gynecol. 2005. PMID: 16338779 Free PMC article. Clinical Trial.

RESULTS: The median time to first relief of symptoms occurred at 17.5 h for butoconazole patients as compared to 22.9 h for fluconazole patients (p < 0.001). The time at which 75% of patients experienced first relief of symptoms was 24.5 h versus 46.3 h for butoconaz

…
RESULTS: The median time to first relief of symptoms occurred at 17.5 h for butoconazole patients as compared to 22.9 h for fluconazo …
Comparison of three-day butoconazole treatment with seven-day miconazole treatment for vulvovaginal candidiasis.
Kaufman RH, Henzl MR, Brown D Jr, Horner DS, Krauss RH, Mehlisch DR, Moore DE, Prentice RL. Kaufman RH, et al. J Reprod Med. 1989 Jul;34(7):479-83. J Reprod Med. 1989. PMID: 2671362 Clinical Trial.
Eight to ten days after treatment completion, 88% of the butoconazole-treated patients and 91% of the miconazole-treated patients were Candida negative; 80% of the butoconazole-treated patients and 82% of the miconazole-treated patients were considered clinically cu …
Eight to ten days after treatment completion, 88% of the butoconazole-treated patients and 91% of the miconazole-treated patients wer …
Candidiasis.
Powderly WG. Powderly WG. J Int Assoc Physicians AIDS Care. 1996 Oct;2(10):36-9. J Int Assoc Physicians AIDS Care. 1996. PMID: 11363911
Antifungal agents for oral or esophageal candidiasis may include nystatin, clotrimazole, ketoconazole, fluconazole, itraconazole, or amphotericin B; vulvovaginal disease is treated with clotrimazole, miconazole, or butoconazole in cream or suppository form. Since relapses …
Antifungal agents for oral or esophageal candidiasis may include nystatin, clotrimazole, ketoconazole, fluconazole, itraconazole, or amphote …
Effect of butoconazole nitrate 2% vaginal cream and miconazole nitrate 2% vaginal cream treatments in patients with vulvovaginal candidiasis.
Lappin MA, Brooker DC, Francisco CA, Dorfman J. Lappin MA, et al. Infect Dis Obstet Gynecol. 1996;4(6):323-8. doi: 10.1155/S1064744996000658. Infect Dis Obstet Gynecol. 1996. PMID: 18476119 Free PMC article.
In a multicenter, randomized, invesgtigator-blind, parallel study, 398 patients were dispensed topical butoconazole nitrate 2% cream for 3 days (n = 199) or miconazole nitrate 2% cream for 7 days (n = 199) for vaginal use. Efficacy analyses included 254 patients with cultu …
In a multicenter, randomized, invesgtigator-blind, parallel study, 398 patients were dispensed topical butoconazole nitrate 2% cream …
Three-day treatment with butoconazole nitrate for vulvovaginal candidiasis.
Droegemueller W, Adamson DG, Brown D, Cibley L, Fleury F, LePage ME, Henzl MR. Droegemueller W, et al. Obstet Gynecol. 1984 Oct;64(4):530-4. Obstet Gynecol. 1984. PMID: 6384848 Clinical Trial.
A multicenter clinical trial of 274 patients compared the efficacy and safety of a new vaginal antifungal compound, butoconazole nitrate cream 2% (butoconazole), to clotrimazole vaginal tablets 200 mg/day (clotrimazole). ...Complete absence of the entrance signs and …
A multicenter clinical trial of 274 patients compared the efficacy and safety of a new vaginal antifungal compound, butoconazole nitr …
72 results